IDENTIFICATION OF NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH RENAL-CELL CARCINOMA

Citation
Br. Konety et al., IDENTIFICATION OF NUCLEAR MATRIX PROTEIN ALTERATIONS ASSOCIATED WITH RENAL-CELL CARCINOMA, The Journal of urology, 159(4), 1998, pp. 1359-1363
Citations number
44
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00225347
Volume
159
Issue
4
Year of publication
1998
Pages
1359 - 1363
Database
ISI
SICI code
0022-5347(1998)159:4<1359:IONMPA>2.0.ZU;2-E
Abstract
Purpose: Neoplastic transformation, including renal cell carcinoma (RC C), is always accompanied by changes in nuclear morphology. Nuclear gr ading of RCC is based on characteristic alterations in nuclear shape, size, area and other morphologic parameters. The nuclear matrix, which forms the skeleton of the nucleus, determines nuclear morphology. Alt erations in nuclear matrix protein (NMP) composition specific to tissu e and cancer type have been described in a variety of human cancers. W e conducted a study to analyze the nuclear matrix protein composition of renal cell carcinoma and compare it to that of normal renal tissue and renal cell carcinoma cells grown in culture. Materials and Methods : We analyzed the nuclear matrix protein composition of RCC tumor tiss ue and that of normal kidney tissue obtained from seventeen patients u ndergoing radical nephrectomy for RCC. We also analyzed the NMP compos ition of two renal cancer cell lines (A-498 and 769-P). Results: We we re able to identify five different and unique NMPs which were present only in the human RCC tumor samples and were absent in all normal kidn ey tissue. One NMP was found specifically in the normal kidney tissue. All five RCC specific NMPs were also identified in the nuclear matrix of the two cell lines analyzed. Conclusions: Five nuclear matrix prot eins specific and unique to RCC were identified. These NMPs are differ ent from those previously identified in other tissues and neoplasms. T he RCC specific NMPs identified in this study can potentially be used as diagnostic markers for renal cell carcinoma and for therapeutic tum or targeting.